ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2016

Esophageal Disease in Systemic Sclerosis: Does Heritability Play a Role?

Latifa Fakoya1, Kathryn Peterson2, Andrew Gawron2, Jathine Wong3, Mary Beth Scholand4, Allen D. Sawitzke5 and Tracy M. Frech6,7, 1Internal Medicine/Rheumatology, University of Utah, Salt Lake City, UT, 2Internal Medicine/Gastroenterology, University of Utah, Salt Lake City, UT, 3University of Utah, Salt Lake, UT, 4University of Utah, Salt Lake City, UT, 5Rheumatology, Univ of Utah, Salt Lake City, UT, 6Internal Medicine, Salt Lake City VAMC, Salt Lake, UT, 7Internal Medicine-Division of Rheumatology, University of Utah School of Medicine, SLC, UT

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Epidemiologic methods, Gastrointestinal complications and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics II

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Systemic sclerosis (SSc) associated gastroesophageal reflux disease (GERD) can cause symptoms of dysphagia and heartburn, and is associated with esophagitis, stricture, Barrett’s esophagus, and esophageal adenocarcinoma. A genealogic resource, the Utah Population Database (UPDB) has successfully identified systemic sclerosis (SSc) pedigrees and comparable hereditable risk for this disease. We hypothesized that these pedigrees could be used to assess for the hereditability of esophageal disease in order to risk stratify SSc patients with esophageal symptoms and inform their monitoring needs.

Methods: SSc (ICD-9 710.1 and ICD-10 M34.0, M34.1, and M34.9), GERD (ICD-9 530.1 and ICD-10 K21.9), dysphagia (ICD-9 787.20), esophageal stricture (ICD9 530.3 and ICD10 K 22.2), Barrett’s esophagus (ICD-9 530.85 and ICD-10 K22.7), and esophageal adenocarcinoma (ICD-9 150.9 and ICD-10 C15.9) was identified from statewide discharge data, the University of Utah Health Science Center Enterprise Data Warehouse, and death certificates and were linked to the UPDB for analysis. SSc probands that had pedigree information for first, second, and third degree relatives were analyzed for the presence of each of the aforementioned diagnostic codes. Inheritance was evaluated by familial standardized incidence ratio and relative risks (RR) to first, second, third, fourth degree relatives and spouses for cases of SSc. Five matched controls were selected from the statewide UPDB population file without replacement in a Monte Carlo method to simulate random sampling in this low penetrate disease. The controls were matched on gender, birth year, and whether they were born in Utah.

Results: A software kinship analysis tool analyzed 2227 unique SSc patients and 11136 controls. In this study, 15% of the SSc from the Utah population is familial based on calculated population attributable risk. The SSc proband had a significant presence of esophageal symptoms and disease: GERD (RR: 3.28), dysphagia (RR 5.58), esophageal stricture (RR: 5.16), esophagitis (RR: 4.86), and Barrett’s (RR: 4.52 (all p<2e-16) as expected. In a first-degree relative of a SSc proband GERD (RR: 1.14, p=6.85e-05), dysphagia (RR: 1.22 p=0.002), and esophagitis (RR: 1.37, p=2.10e-06) were significantly seen in SSc first degree relatives (parents and children). Esophagitis and dysphagia was significantly seen in first cousins (RR: 1.09, p=0.03) and spouses (RR; 1.37, p=0.02), suggesting that both genetics and similar exposures (ie, diet) may play a role in pathogenesis. Esophageal stricture and Barrett’s esophagus do not appear to be hereditable and were also not seen in spouses. None of the SSc cases had esophageal adenocarcinoma.

Conclusion: The UPDB is a resource that allows for meaningful inheritance analysis. These data suggest that independent of GERD, esophagitis in SSc patients and their relatives may have both a hereditable and environmental etiology. Importantly, there does not seem to be a heritable component to Barrett’s esophagus in this population suggesting that modulation of reflux may play an important role in prevention.


Disclosure: L. Fakoya, None; K. Peterson, None; A. Gawron, None; J. Wong, None; M. B. Scholand, None; A. D. Sawitzke, None; T. M. Frech, None.

To cite this abstract in AMA style:

Fakoya L, Peterson K, Gawron A, Wong J, Scholand MB, Sawitzke AD, Frech TM. Esophageal Disease in Systemic Sclerosis: Does Heritability Play a Role? [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/esophageal-disease-in-systemic-sclerosis-does-heritability-play-a-role/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/esophageal-disease-in-systemic-sclerosis-does-heritability-play-a-role/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology